Professor, The Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases,
The Feinstein Institute for Medical Research
Professor, Molecular Medicine & Otolaryngology,
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Phone: (718) 470-7550
Dr. Vambutas is a clinician scientist. She is the medical director of the Apelian Cochlear Implant Program and the Section Head of Otology/Neurotology of Northwell Health. She is professor of Otolaryngology & Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. She is a professor in the Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, at the Feinstein Institute for Medical Research. She is also director of the Center for Hearing & Balance and Basic & Clinical Research, at the New York Head & Neck Institute of Northwell Health.
Dr. Vambutas completed her medical school training at the Albert Einstein College of Medicine with a medical degree with distinction in research. She was an Otolaryngology resident at Long Island Jewish Medical Center, and completed her fellowship training in Otology & Neurotology with Dr. Michael Paparella, in Minneapolis, Minnesota.
There are three unique forms of hearing loss that may be amenable to medical therapy for recovery of natural hearing: Autoimmune Inner Ear Disease, Sudden Sensorineural Hearing Loss and Meniere’s Disease. Timely treatment with steroids results in hearing recovery in about 60% of cases. Unfortunately, that response is lost over time with repetitive treatment. For those that fail to respond to corticosteroids, there are no alternate treatments. We rehabilitate the hearing with hearing aids or cochlear implants. Despite how beneficial these devices are, they do not select for what we want to hear, unlike our brains that do it naturally and seamlessly.
Our research interests are in the restoration of natural hearing in these steroid resistant patients. To this end, we have identified the critical role of an inflammatory protein, interleukin-1 (IL-1), in this disease, and have hypothesized that blocking IL-1 may ameliorate this type of hearing loss. To test the hypothesis, we are presently running a NIH-sponsored phase I open-label clinical trial to determine if blockade of IL-1 can prevent further hearing loss in these corticosteroid-resistant individuals. We are also trying to better understand the molecular mechanisms behind these diseases, specifically in distinguishing corticosteroid sensitive and resistant hearing loss which would identify new biologic markers of disease.
Shresh Pathak, PhD
Assistant Professor of Otolaryngology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Research: Studies the molecular mechanisms of pro-inflammatory cytokines in peripheral blood immune cells from patients with immune mediated hearing loss.
2002 Teacher of the Year, Dept. of Otolaryngology, Albert Einstein College of Medicine, Montefiore Medical Center
2005-present Best Doctors
2007 Outstanding Teacher Award, Northwell Health
2008 Teacher of the Year, Dept. of Otolaryngology, Albert Einstein College of Medicine, Montefiore Medical Center
2009-present Castle Connolley Best Doctors
2009 Service Award, American Academy of Otolaryngology HNS